These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 16831210

  • 1. Enhanced immunoprotective potential of Mycobacterium tuberculosis Ag85 complex protein based vaccine against airway Mycobacterium tuberculosis challenge following intranasal administration.
    Giri PK, Verma I, Khuller GK.
    FEMS Immunol Med Microbiol; 2006 Jul; 47(2):233-41. PubMed ID: 16831210
    [Abstract] [Full Text] [Related]

  • 2. Comparative evaluation of intranasal and subcutaneous route of immunization for development of mucosal vaccine against experimental tuberculosis.
    Giri PK, Sable SB, Verma I, Khuller GK.
    FEMS Immunol Med Microbiol; 2005 Jul 01; 45(1):87-93. PubMed ID: 15985227
    [Abstract] [Full Text] [Related]

  • 3. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E, Nicolle F, Clark S, Majlessi L, Boudou F, Martino A, Castello-Branco L, Leclerc C, Lewis DJ, Marsh PD, Gicquel B, Winter N.
    Vaccine; 2009 Jan 01; 27(1):28-37. PubMed ID: 18977269
    [Abstract] [Full Text] [Related]

  • 4. Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice.
    Giri PK, Verma I, Khuller GK.
    J Infect; 2006 Nov 01; 53(5):350-6. PubMed ID: 16442629
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis.
    Tang C, Yamada H, Shibata K, Maeda N, Yoshida S, Wajjwalku W, Ohara N, Yamada T, Kinoshita T, Yoshikai Y.
    J Infect Dis; 2008 May 01; 197(9):1263-74. PubMed ID: 18422438
    [Abstract] [Full Text] [Related]

  • 6. Subcutaneous administration of modified vaccinia virus Ankara expressing an Ag85B-ESAT6 fusion protein, but not an adenovirus-based vaccine, protects mice against intravenous challenge with Mycobacterium tuberculosis.
    You Q, Jiang C, Wu Y, Yu X, Chen Y, Zhang X, Wei W, Wang Y, Tang Z, Jiang D, Wu Y, Wang C, Meng X, Zhao X, Kong W.
    Scand J Immunol; 2012 Jan 01; 75(1):77-84. PubMed ID: 21916923
    [Abstract] [Full Text] [Related]

  • 7. Mucosal prime-boost vaccination for tuberculosis based on TLR triggering OprI lipoprotein from Pseudomonas aeruginosa fused to mycolyl-transferase Ag85A.
    Gartner T, Baeten M, Otieno S, Revets H, De Baetselier P, Huygen K.
    Immunol Lett; 2007 Jul 31; 111(1):26-35. PubMed ID: 17570535
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
    Deng YH, He HY, Zhang FJ.
    Scand J Immunol; 2013 Dec 31; 78(6):497-506. PubMed ID: 24283772
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
    Wang QL, Pan Q, Ma Y, Wang K, Sun P, Liu S, Zhang XL.
    Vaccine; 2009 Nov 12; 27(48):6712-22. PubMed ID: 19733584
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Protection against Mycobacterium tuberculosis challenge in mice by DNA vaccine Ag85A-ESAT-6-IL-21 priming and BCG boosting.
    Dou J, Wang Y, Yu F, Yang H, Wang J, He X, Xu W, Chen J, Hu K.
    Int J Immunogenet; 2012 Apr 12; 39(2):183-90. PubMed ID: 22152009
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice.
    Liu S, Gong Q, Wang C, Liu H, Wang Y, Guo S, Wang W, Liu J, Shao M, Chi L, Zhao K, Wang Z, Shi Y, Huang Y, Guli A, Zhang C, Kong X.
    Immunol Lett; 2008 May 15; 117(2):136-45. PubMed ID: 18339431
    [Abstract] [Full Text] [Related]

  • 17. Immune response and protection by DNA vaccines expressing antigen 85B of Mycobacterium tuberculosis.
    Pardini M, Giannoni F, Palma C, Iona E, Cafaro A, Brunori L, Rinaldi M, Fazio VM, Laguardia ME, Carbonella DC, Magnani M, Ensoli B, Fattorini L, Cassone A.
    FEMS Microbiol Lett; 2006 Sep 15; 262(2):210-5. PubMed ID: 16923077
    [Abstract] [Full Text] [Related]

  • 18. Enhanced protection against tuberculosis by vaccination with recombinant BCG over-expressing HspX protein.
    Shi C, Chen L, Chen Z, Zhang Y, Zhou Z, Lu J, Fu R, Wang C, Fang Z, Fan X.
    Vaccine; 2010 Jul 19; 28(32):5237-44. PubMed ID: 20538090
    [Abstract] [Full Text] [Related]

  • 19. The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis.
    Andersen CS, Dietrich J, Agger EM, Lycke NY, Lövgren K, Andersen P.
    Infect Immun; 2007 Jan 19; 75(1):408-16. PubMed ID: 17074845
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.